ECM
ADMA icon

Element Capital Management’s ADMA Biologics ADMA Stock Holding History

Element Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,663
Closed -$118K – 809
2018
Q1 		$118K Buy
+25,663
New +$102K ﹤0.01% 767

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $131M AUM 101.21% 1-Year Est. Return

Element Capital Management's ADMA Position: Q2 2018 in Review

Element Capital Management sold out of ADMA Biologics (ADMA) in Q2 2018, closing a stake of 25,663 shares — an estimated $118K sold.

Element Capital Management first reported a position in ADMA in Q1 2018 and held it in 1 quarter. The position peaked at $118K in Q1 2018. 55 funds tracked by Wall St. Rank hold ADMA as of Q2 2018.

  • Element Capital Management reported no remaining ADMA Biologics position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 25,663 ADMA Biologics shares in Q2 2018, an estimated $118K.
  • Element Capital Management first reported a position in ADMA Biologics in Q1 2018 and held it in 1 quarter.
  • Element Capital Management's ADMA Biologics position peaked at $118K in Q1 2018.
  • 55 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.